Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 18Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 10Lymphoma 10Burkitt Lymphoma 8Graft vs Host Disease 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Non-Hodgkin 5Leukemia, Neutrophilic, Chronic 5Congenital Abnormalities 5Thrombocythemia, Essential 4Primary Myelofibrosis 4Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Biphenotypic, Acute 4Hodgkin Disease 4Hematologic Neoplasms 4Neoplasms, Plasma Cell 3

Interventions

Dexamethasone 7daratumumab 3Peripheral Blood Stem Cell Transplantation 3Calcium Dobesilate 3venetoclax 2pomalidomide 2ixazomib 2fludarabine phosphate 2Whole-Body Irradiation 2Mycophenolic Acid 2Lenalidomide 2Cyclosporine 2Cyclophosphamide 2ethanolamine oleate 1dexamethasone acetate 1carfilzomib 1birtamimab 1belantamab mafodotin 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Thalidomide 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Phenytoin 1Pentetic Acid 1Methotrexate 1Melphalan 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Immunoglobulin Light-chain Amyloidosis × Methotrexate × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡